ANTICOAGULANT CITRATE DEXTROSE A- anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate solution 
Citra Labs

----------

ACD-A

Anticoagulant Citrate Dextrose Solution,

Solution A, U.S.P., PN 9350, 30 mL

NDC 23731-6051-3

Description

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains:

Citric Acid, anhydrous, USP0.073 g
Sodium Citrate, dihydrate, USP0.220 g
Dextrose, monohydrate, USP0.245 g
Water for Injection, USPq.s.
pH: 4.5 – 5.5

single use Single patient use only, on a single occasion.

Clinical Pharmacology

ACD-A acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium, thus making calcium unavailable to the coagulation system.

Indications and Usage

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Contraindications

NOT FOR DIRECT INTRAVENOUS INFUSION

Warnings

NOT FOR DIRECT INTRAVENOUS INFUSION

Precautions

General

  • Aseptic technique must be maintained at all times.
  • ACD-A solution is a clear and colorless solution. If the product shows any cloudiness or turbidity, the product should be discarded.
  • The closure system provides a biological barrier and should be intact – discard product if system is compromised.

Information for Patients

None.

Carcinogenesis, mutagenesis, impairment of fertility

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ACD-A.

Pregnancy

Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

Pediatric Use

The safety and effectiveness of ACD-A in children have not been established.

Adverse Reactions

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Overdosage

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP systems in production of platelet rich plasma (PRP).

Dosage and Administration

Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Rx Only

Caution: Federal Law (US) restricts this devise to sale by or on the order of a Physician.

How Supplied

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A)

 REFSIZECASE
 PN 9350-1030 mL10 Vials/Case
 PN 9350-2530 mL25 Vials/Case

It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F); however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.

Manufactured & Distributed by:
CitraLabs™
55 Messina Drive, Braintree, MA 02184
Phone Number: 1-800-299-3411

Authorized Representative:
Biomet U.K. Ltd.
Waterton Industrial Estate
Bridgend, South Wales, CF31 3XA
Great Britain
United Kingdom
Phone 441.65.66.55.221

Principal Display Panel

PRINCIPAL DISPLAY PANEL - 10 Vial Case Label

C E 0044

ACD-A

Anticoagulant Citrate Dextrose Solution,

10 Vials / Case Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-10

WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with

Autologous PRP Systems in production of platelet rich plasma (PRP).

Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs

A Biomet Biologics Company

Citra Labs, LLC.

55 Messina Drive, Braintree, MA 02184

1-800-299-3411

EC REP

Authorized Representative:

Biomet U.K. Ltd.,

Waterton Industrial Estate

Bridgend, South Wales, CF31 3XA

Great Britain - United Kingdom

Phone 441.65.66.55.221

symbols

STERILE • NON-PYROGENIC

Composition per 10 mL of Solution:

Citric Acid, (Anhydrous), U.S.P. 0.073 g.

Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.

Dextrose, (Monohydrate), U.S.P. 0.245 g.

CAUTION: Single Procedure Use-Discard Unused Portion

Do Not Use Unless Solution is Clear and Seal is Intact.

Store Between 15 °C - 30 °C (59 °F - 86 °F).

RX Only:

EXP DATE

LOT

LA9350-10B 02/15

label

ANTICOAGULANT CITRATE DEXTROSE A 
anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:23731-6051
Route of AdministrationEXTRACORPOREAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE0.245 g  in 10 mL
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID0.073 g  in 10 mL
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID0.22 g  in 10 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:23731-6051-330 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
2NDC:23731-6051-110 in 1 CASE
2NDC:23731-6051-330 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
3NDC:23731-6051-225 in 1 CASE
3NDC:23731-6051-330 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDABN02003708/26/2003
Labeler - Citra Labs (962863838)
Establishment
NameAddressID/FEIBusiness Operations
Citra Labs962863838manufacture(23731-6051)

Revised: 2/2018
Document Id: 663761c2-0c5c-9ea5-e053-2a91aa0ad87f
Set id: 5bcd261e-ebba-4ecb-af22-e5aaeb04499b
Version: 4
Effective Time: 20180227
 
Citra Labs